Ministry for Health authorizes Sputnik V vaccine for emergency use

Caracas.- The Ministry for Health registered the Sputnik V vaccine against Covid-19, under the authorization procedure for emergency use, as announced by the Russian Direct Investment Fund (RDIF).

It should be noted that in the country clinical trials of phase III of the biological are being carried out, indicates a press release from the RDIF, AVN review.

“We welcome the decision of the Venezuelan Ministry of Health to approve the use of Sputnik V, a safe and effective vaccine to prevent the spread of the coronavirus. Sputnik V is now an important part of the national vaccine portfolios of several countries of Latin America and we hope that in the coming weeks there will be more vaccine associations in the region, “said Kirill Dmitriev, general director of the Russian Direct Investment Fund.

For the record, it was taken into account that said vaccine has an efficacy greater than 90%, with total protection against severe cases of Covid-19.

It also uses two different vectors for the two injections in a vaccination course, providing longer-lasting immunity than vaccines that use the same delivery mechanism for both injections.

The safety, efficacy and absence of long-term negative effects of adenoviral vaccines have been proven by more than 250 clinical studies over two decades, while severe allergies caused by Sputnik V.

Notably, the developers of Sputnik V are working in collaboration with AstraZeneca on a joint clinical trial to improve the efficacy of this laboratory’s vaccine.

Sputnik V has been approved in Russia, Belarus, Serbia, Argentina, Bolivia, Algeria and Palestine, while the approval process has already started in the European Union.

The vaccine supply will be facilitated by the international partners of the Russian Direct Investment Fund in India, China, South Korea and other countries.